Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

2 thoradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry

    #683117

    IATE #3543769
    foirm sholadach dáileogachta arna dáileadh ó bhéal Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    solid oral dosage form | solid oral pharmaceutical form | oral solid dosage form | oral solid pharmaceutical form
    en
    Sainmhíniú "pharmaceutical form that is solid and administered orally" Tagairt "COM-Terminology Coordination, based on: Hummler, H., Page, S., Stillhart, C., et al., 'Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults' (14.5.2025), Pharmaceutics 15(4), 2023, 1315."
    forme pharmaceutique solide orale | dose solide à prendre oralement
    fr
    Sainmhíniú "forme pharmaceutique [ IATE:1106950 ] sous forme solide destinée à être ingérée par voie orale" Tagairt "COM-FR, d'après:Wikipédia, Phase biopharmaceutique, http://fr.wikipedia.org/wiki/Phase_biopharmaceutique [23.10.2012]"
  2. SOCIAL QUESTIONS|health|pharmaceutical industry

    #644054

    IATE #3518728
    foirmliú béil tobscaoilte Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    orale Darreichungsform mit sofortiger Wirkstofffreigabe
    de
    immediate-release oral pharmaceutical form | immediate-release oral dosage form | immediate release solid oral dosage form | immediate-release oral formulation
    en
    Sainmhíniú "medicinal product1 formulated to allow the drug to dissolve in the gastrointestinal contents, with no intention of delaying or prolonging the dissolution or absorption of the drug1 medicinal product [ IATE:1443220 ]" Tagairt "COM-Terminology Coordination, based on:FDA. Guidance for Industry SUPAC-MR: Modified Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, http://www.fda.gov/downloads/Drugs/Guidances/UCM070640.pdf [30.6.2014]"
    forme orale à libération immédiate | forme solide pour voie orale à libération immédiate
    fr